Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus

Lupus

Volumn 16, Issue 12, 2007, Pages 963-971

  Appenzeller, S ^a   Li, L M ^a   Costallat, L T L ^a   Cendes, Fernando ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Choline; Spectroscopy; Systemic lupus erythematosus; White matter lesions

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS CALLOSUM; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER;

ADOLESCENT; ADULT; BRAIN; CHOLINE; CREATINE; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NERVE TISSUE; PHOSPHOCREATINE;

EID: 37849007901     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307084723     Document Type: Article

References (57)

1. Castellino G, Govoni M, Padovan M, Colamussi P, Borrelli M, Trotta F. Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up. Ann Rheum Dis 2005; 64: 1022-1027.
2. Stimmler MM, Coletti PM, Quismorio FP. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 1993; 22: 335-349.
3. McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1998; 31: 159-166.
4. Bell CL, Partington C, Robbins M, Graziano F, Turski P, Kornguth S. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum 1991; 34: 432-441.
5. Sibbitt WL Jr, Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 1014-1022.
6. Aisen AM, Gabrielsen TO, McCune WJ. MR imaging of systemic lupus erythematosus involving the brain. Am J Roentgenol 1985; 144: 1027-1031.
7. West SG, Woodruff E, Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 1995; 99: 153-163.
8. Karassa FB, Ioannidis JP, Boki KA et al. Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 2000; 109: 628-634.
9. Sanna G, Piga M, Terryberry JW et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000; 9: 573-583.
10. Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P. Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 2004; 46: 15-21.
11. Colamussi P, Giganti M, Cittanti C et al. Brain single-photon emission tomography with 99mTc HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med 1995; 22: 17-24.
12. Nossent JC, Hovestadt DH, Schonfeld DHW, Swaak AJG. Single-photon emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum 1991; 34: 1397-1403.
13. Rubbert A, Marienhagen J, Pirner K et al. Single photon emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1253-1262.
14. Sibbitt WL, Sibbitt RR. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 1993; 19: 851-868.
15. Castillo M, Kwock L, Mukhery I. Clinical applications of proton MR spectroscopy. Am J Neuroradiol 1996; 17: 1-15.
16. Narayana PA. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging 2005; 15: 46S-57S.
17. Sibbitt WL Jr, Haseler LJ, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. Am J Neuroradiol 1994; 15: 923-928.
18. Handa R, Sahota P, Kumar M et al. In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE). Magn Reson Imaging 2003; 21: 1033-1037.
19. Lim MK, Suh CH, Kim HJ et al. Systemic lupus erythematosus: brain MR imaging and single-voxel hydrogen MR spectroscopy. Radiology 2000; 217: 43-49.
20. Axford JS, Howe FA, Heron C, Griffiths JR. Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus. Ann Rheum Dis 2001; 60: 106-111.
21. Peterson PL, Howe FA, Clark CA, Axford JS. Quantitative magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus. Lupus 2003; 12: 897-902.
22. Appenzeller S, Li LM, Costallat LT, Cendes F. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study. Brain 2005; 128: 2933-2940.
23. Tartaglia MC, Narayanan S, De Stefano N et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 2002; 249: 1382-1390.
24. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
25. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
26. Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anticardiolipine antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-222.
27. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74: 1185-1190.
28. ACR Ad Hoc Committee on Neuropsychiatric Lupus. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
29. Folstein MF, Folstein SE, Folstein PR. 'Mini mental state': a practical method for grading the cognitive state of patient for the clinician. J Psychiatr Res 1975; 12: 189-198.
30. Spranoel HZ. The psychoeducational use and interpretation of the Wechsler adult intelligence scale-revised. Springfield: CC Thomas, 1992.
31. Wechsler in Muistiasteikko, Suom. Anja Manner. Helsinki: Psykologien Kustannus, 1986.
32. Delis DC, Kramer JH, Kaplan E et al. California verbal learning test research edition manual. San Antonio, TX: The Psychological Corporation, 1987.
33. Lezak MD. Neuropsychological assessment. NY: Oxford University Press, 1995.
34. Heaton RK, Chelune GJ, Talley JL et al. Wisconsin card sorting test manual, revised and expanded. Odessa: Psychological Assessment Resources, Inc., 1993.
35. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiat 1974; 7: 151-169.
36. Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep 1974; 34: 1184-1186.
37. Herrmann C. International experiences with the hospital anxiety and depression scale-a review of validation data and clinical results. J Psychosom Res 1997; 42: 17-41.
38. Overall JE, Beller SA. The brief psychiatric rating scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. J Gerontol 1984; 39: 187-193.
39. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8: 1-96.
40. Pajaron E, Lainez JM, Monzon MJ, Parra J, Peiro C, Sancho J. The validity of the classification criteria of the international headache society for migraine, tension headache and chronic tension headache. Neurologia 1999; 14: 283-288.
41. Bensenor IJ, Lotufo PA, Pereira AC et al. Validation of a questionnaire for the diagnosis of headache in an outpatient clinic at a university hospital. Arq Neuropsiquiatr 1997; 55: 364-369.
42. Appenzeller S, Costallat LT. Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage. Cephalalgia 2004; 24: 1024-1030.
43. Gladman DD, Urowitz MB, Kagal A, Hallett D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 2000; 27: 377-379.
44. Gladman DD, Urowitz MB, Goldsmith CH et al. The reliability of the systemic lupus international collaborating clinics/American college of rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809-813.
45. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987; 508: 333-348.
46. Appenzeller S, Rondina JM, Li LM, Costallat LT, Cendes F. Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 2783-2789.
47. Sibbitt WL, Brooks WM, Haseler LJ et al. Spin-spin relaxation of brain tissues in systemic lupus erythematosus: method for increasing the sensitivity of magnetic resonance imaging for neuropsychiatric lupus. Arthritis Rheum 1995; 38: 810-818.
48. Rozell CL, Sibbitt WL, Brooks WM. Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus. Cephalalgia 1998; 18: 209-215.
49. Sabet A, Sibbitt WL Jr, Stidley CA, Danska J, Brooks WM. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 1998; 29: 2254-2260.
50. Sibbitt WL Jr, Haseler LJ, Griffey RR, Friedman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. AJNR Am J Neuroradiol 1997; 18: 1271-1277.
51. Brooks WM, Sabet A, Sibbitt WL Jr et al. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol 1997; 24: 2323-2329.
52. Brooks WM, Jung RE, Ford CC, Greinel EJ, Sibbitt WL Jr. Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus. J Rheumatol 1999; 26: 81-85.
53. Sundgren PC, Jennings J, Attwood JT et al. MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology 2005; 47: 576-585.
54. Rudkin TM, Arnold DL. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. Arch Neurol 1999; 56: 919-926.
55. Appenzeller S, Costallat LT, Li LM, Cendes F. Magnetic resonance spectroscopy in the evaluation of central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 2006; 55: 807-811.
56. De Certaines JD, Bovee WM, Podo F. Magnetic resonance spectroscopy in biology and medicine: functional and pathological tissue characterization. NY: Pergamon Press; 1992.
57. Gujar SK, Maheshwari S, Bjorkman-Burtscher I, Sundgren PC. Magnetic resonance spectroscopy. J Neuroophthalmol 2005; 25: 217-226.